{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:29:53Z","timestamp":1765546193916},"reference-count":25,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/jcpt.12531","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T04:42:39Z","timestamp":1494391359000},"page":"502-505","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacist intervention to detect drug adverse events on admission to the emergency department: Two case reports of neuroleptic malignant syndrome"],"prefix":"10.1155","volume":"42","author":[{"given":"F.","family":"Leenhardt","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Perier","sequence":"additional","affiliation":[{"name":"Emergency Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pinzani","sequence":"additional","affiliation":[{"name":"Medical Pharmacology and Toxicology Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Giraud","sequence":"additional","affiliation":[{"name":"Emergency Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Villiet","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Castet-Nicolas","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gourhant","sequence":"additional","affiliation":[{"name":"Emergency Department; University Hospital; Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Breuker","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department; University Hospital; Montpellier France"},{"name":"PhyMedExp; INSERM U1046; CNRS UMR 9214; University of Montpellier; France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"10.1111\/jcpt.12531-BIB0001|jcpt12531-cit-0001","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11940-016-0423-4","article-title":"Management of serotonin syndrome and neuroleptic malignant syndrome","volume":"18","author":"Katus","year":"2016","journal-title":"Curr Treat Options Neurol"},{"key":"10.1111\/jcpt.12531-BIB0002|jcpt12531-cit-0002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159X13999150424113345","article-title":"Neuroleptic malignant syndrome: a review from a clinically oriented perspective","volume":"13","author":"Tse","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.1111\/jcpt.12531-BIB0003|jcpt12531-cit-0003","first-page":"155","article-title":"Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management","volume":"24","author":"Perry","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0004|jcpt12531-cit-0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/bja\/85.1.129","article-title":"Neuroleptic malignant syndrome","volume":"85","author":"Adnet","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1111\/jcpt.12531-BIB0005|jcpt12531-cit-0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1440-1819.2009.02042.x","article-title":"Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death","volume":"64","author":"Tural","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1111\/jcpt.12531-BIB0006|jcpt12531-cit-0006","first-page":"517","article-title":"Neuroleptic malignant syndrome","volume":"55","author":"Bristow","year":"1996","journal-title":"Br J Hosp Med"},{"key":"10.1111\/jcpt.12531-BIB0007|jcpt12531-cit-0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","article-title":"Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis","volume":"15","author":"Belvederi Murri","year":"2015","journal-title":"Drugs R&D"},{"key":"10.1111\/jcpt.12531-BIB0008|jcpt12531-cit-0008","first-page":"439","article-title":"Neuroleptic malignant syndrome: case report and discussion","volume":"169","author":"Chandran","year":"2003","journal-title":"CMAJ"},{"key":"10.1111\/jcpt.12531-BIB0009|jcpt12531-cit-0009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4187\/respcare.01324","article-title":"An atypical presentation of neuroleptic malignant syndrome: diagnostic dilemma in a critical care setting","volume":"57","author":"Paul","year":"2012","journal-title":"Respir Care"},{"key":"10.1111\/jcpt.12531-BIB0010|jcpt12531-cit-0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pds.1937","article-title":"Neuroleptic malignant syndrome and its controversies","volume":"19","author":"Margetic","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12531-BIB0011|jcpt12531-cit-0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/NDT.S118438","article-title":"Neuroleptic malignant syndrome: an easily overlooked neurologic emergency","volume":"13","author":"Oruch","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1111\/jcpt.12531-BIB0012|jcpt12531-cit-0012","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4088\/JCP.10m06438","article-title":"An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method","volume":"72","author":"Gurrera","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0013|jcpt12531-cit-0013","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/1060028016657553","article-title":"Neuroleptic malignant syndrome review: focus on treatment and rechallenge","volume":"50","author":"Pileggi","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12531-BIB0014|jcpt12531-cit-0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.encep.2016.01.001","article-title":"Syndrome malin des neuroleptiques et difficultes diagnostiques: a propos d'un cas","volume":"42","author":"Khouri","year":"2016","journal-title":"L'Encephale"},{"key":"10.1111\/jcpt.12531-BIB0015|jcpt12531-cit-0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0016|jcpt12531-cit-0016","first-page":"1229","article-title":"Neuroleptic malignant syndrome","volume":"40","author":"Lazarus","year":"1989","journal-title":"Hosp Community Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0017|jcpt12531-cit-0017","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0018|jcpt12531-cit-0018","first-page":"151","article-title":"Epidemiology of neuroleptic malignant syndrome","volume":"22","author":"Adityanjee","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/jcpt.12531-BIB0019|jcpt12531-cit-0019","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.143.10.1227","article-title":"Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital","volume":"143","author":"Pope","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0020|jcpt12531-cit-0020","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/JGP.0b013e3181b7ef6e","article-title":"Risk of death related to psychotropic drug use in older people during the European 2003 heatwave: a population-based case-control study","volume":"17","author":"Nordon","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0021|jcpt12531-cit-0021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007611-200295080-00006","article-title":"Drug-associated heat stroke","volume":"95","author":"Martinez","year":"2002","journal-title":"South Med J"},{"key":"10.1111\/jcpt.12531-BIB0022|jcpt12531-cit-0022","first-page":"389","article-title":"AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome","volume":"71","author":"Waldorf","year":"2003","journal-title":"AANA J"},{"key":"10.1111\/jcpt.12531-BIB0023|jcpt12531-cit-0023","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(09)61711-6","article-title":"Health effects of hot weather: from awareness of risk factors to effective health protection","volume":"375","author":"Hajat","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12531-BIB0024|jcpt12531-cit-0024","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1176\/appi.ajp.160.4.796","article-title":"Neuroleptic malignant syndrome and low-dose olanzapine","volume":"160","author":"Suh","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1111\/jcpt.12531-BIB0025|jcpt12531-cit-0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.eurpsy.2007.03.007","article-title":"Psychotropic drugs use and risk of heat-related hospitalisation","volume":"22","author":"Martin-Latry","year":"2007","journal-title":"Eur Psychiatry"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12531","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12531\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T13:51:26Z","timestamp":1692798686000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12531","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}